Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Bleeding in patients with acute myeloid leukemia (AML) receiving intensive induction chemotherapy is multifactorial and contributes to early death. We sought to define the incidence and risk factors of grade 4 bleeding to support strategies for risk mitigation. Bleeding events were retrospectively a...

Descripción completa

Detalles Bibliográficos
Autores principales: Versluis, Jurjen, Pandey, Manu, Flamand, Yael, Haydu, J. Erika, Belizaire, Roger, Faber, Mark, Vedula, Rahul S., Charles, Anne, Copson, Kevin M., Shimony, Shai, Rozental, Alon, Bendapudi, Pavan K., Wolach, Ofir, Griffiths, Elizabeth A., Thompson, James E., Stone, Richard M., DeAngelo, Daniel J., Neuberg, Donna, Luskin, Marlise R., Wang, Eunice S., Lindsley, R. Coleman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092400/
https://www.ncbi.nlm.nih.gov/pubmed/35081257
http://dx.doi.org/10.1182/bloodadvances.2021006166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092400/
https://www.ncbi.nlm.nih.gov/pubmed/35081257
http://dx.doi.org/10.1182/bloodadvances.2021006166

Ejemplares similares